Blog

Opinion: How investors should play gene-therapy stocks – MarketWatch


MarketWatch

Opinion: How investors should play gene-therapy stocks
MarketWatch
While traditional research is usually focused on unlocking a way to treat one condition, gene therapies such as Luxturna may be game changers because they are based on platforms that can be adapted and used to tackle multiple inherited disorders.

Flattr this!

2017-09-05 NEWS
About Michael Zand